Your browser doesn't support javascript.
Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients.
Palich, R; Veyri, M; Marot, S; Vozy, A; Gligorov, J; Maingon, P; Marcelin, A-G; Spano, J-P.
  • Palich R; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Medical Oncology, Pitié Salpêtrière Hospital, Paris, France; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Hea
  • Veyri M; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Medical Oncology, Institut Universitaire de Cancérologie (IUC), CLIP(2) Galilée, Paris, France.
  • Marot S; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Virology, Pitié Salpêtrière Hospital, Paris, France.
  • Vozy A; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Medical Oncology, Institut Universitaire de Cancérologie (IUC), CLIP(2) Galilée, Paris, France.
  • Gligorov J; Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Medical Oncology, Tenon Hospital, Institut Universitaire de Cancérologie (IUC), CLIP(2) Galilée, Paris, France.
  • Maingon P; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Oncology Radiotherapy, Institut Universitaire de Cancérologie (IUC), CLIP(2) Galilée, Paris, France.
  • Marcelin AG; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Virology, Pitié Salpêtrière Hospital, Paris, France.
  • Spano JP; Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Medical Oncology, Institut Universitaire de Cancérologie (IUC), CLIP(2) Galilée, Paris, France.
Ann Oncol ; 32(8): 1051-1053, 2021 08.
Article in English | MEDLINE | ID: covidwho-1210314
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: Ann Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: Ann Oncol Journal subject: Neoplasms Year: 2021 Document Type: Article